文献速递肝病

等待肝移植的肝硬化患者中的端粒酶变异

Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
PubMed 文献 · Hepatology · 2019-04-09

该研究评估了86例终末期肝病患者8个端粒酶复合体相关基因的变异,发现17例(20%)携带可能有害变异,其中RTEL1基因有7种独特变异;任何RTEL1变异与基线白细胞计数降低29%相关,任何外显子错义RTEL1变异与基线血小板计数降低42%相关;任何端粒酶变异与移植后1年内再入院风险增加相关(IRR 3.15),任何外显子错义变异与术后住院时间延长相关(IRR 2.16),未观察到与生存的关联。

要点

  • 86例等待肝移植的终末期肝病患者中,17例(20%)通过计算机分析检出可能有害的端粒酶复合体基因变异。
  • RTEL1基因共检出7种独特的可能有害变异,任何RTEL1变异与基线白细胞计数降低29%相关。
  • 任何端粒酶变异与移植后1年内再入院风险增加相关(IRR 3.15),未观察到与生存的关联。

核心结论

  • 在接受肝移植的患者中,任何外显子错义变异与术后住院时间延长相关,IRR为2.16(95%CI 1.31至3.68)。

研究设计与样本

  • 研究纳入86例等待肝移植的终末期肝病患者,采用包含8个基因的扩展 panel 进行变异评估,并通过计算机分析判定可能有害变异。

主要发现

  • 17例患者(20%)通过计算机分析检出可能有害变异。
  • 在RTEL1基因中鉴定出7种独特的可能有害变异。
  • 与无RTEL1变异的患者相比,携带任何RTEL1变异与基线白细胞计数降低29%相关(95%CI -7%至-46%;P值=0.01)。
  • 与无外显子错义RTEL1变异的患者相比,携带任何外显子错义RTEL1变异与基线血小板计数降低42%相关(95%CI -5%至-65%;P值=0.03)。
  • 携带任何端粒酶变异与移植后1年内再入院次数增加相关,IRR为3.15(95%CI 1.22至8.57);未观察到与生存的关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Telomeres are repetitive DNA sequences that protect the ends of linear chromosomes, and they are maintained by a ribonucleoprotein complex called telomerase. Variants in genes encoding for telomerase components have been associated with a spectrum of disease in the lung, skin, bone marrow, and liver. Mutations in the telomerase reverse transcriptase and telomerase RNA component genes have been observed at a higher prevalence in patients with liver disease compared with the general population; however, the presence of variants in other components of the telomerase complex and their impact on clinical outcomes has not been explored. We evaluated 86 patients with end-stage liver disease for variants in an expanded panel of eight genes, and found that 17 patients (20%) had likely deleterious variants by in silico analysis. Seven unique likely deleterious variants were identified in the regulator of telomere elongation helicase 1 (RTEL1) gene that encodes for a DNA helicase important in telomere maintenance and genomic stability. In gene burden association analysis of their clinical data, the presence of any RTEL1 variant was associated with a 29% lower baseline white blood cell count (95% confidence interval [CI], -7% to -46%; P Value = 0.01) compared with patients without RTEL1 variants, and the presence of any exonic missense RTEL1 variant was associated with a 42% lower baseline platelet count (95% CI, -5% to -65%: P Value = 0.03). The presence of any telomerase variant was associated with an increased number of readmissions within 1 year after transplantation demonstrated by an incident rate ratio (IRR) of 3.15 (95% CI, 1.22 to 8.57). No association with survival was observed. Conclusion: Among patients who underwent liver transplantation, the presence of any exonic missense variant was associated with a longer postoperative length of stay with an IRR of 2.16 (95% CI, 1.31 to 3.68).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Chiu V, Hogen R, Sher L, et al. Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation. Hepatology. 2019. PMID: 30964210. doi:10.1002/hep.30557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。